Search results :

Naftifine

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: D01AE22

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5
Pain Stinging 5% - 6% x x x
Pain postmarketing x
Pruritus Pruritus postmarketing, 1% - 2% x x x x x
Dermatitis Rash postmarketing, 0.5% x x x
Rash Rash postmarketing, 0.5% x x x
Erythema Erythema postmarketing, 0.5% - 2% x x x x
Redness postmarketing x x
Pain of skin Skin tenderness 0.5% x x
Agranulocytosis Agranulocytosis postmarketing x
Blister Blister postmarketing x x
Dermatitis bullous Blister postmarketing x x
Dizziness Dizziness postmarketing x
Headache Headache postmarketing x
Inflammation Inflammation postmarketing x x
Leukopenia Leukopenia postmarketing x
Swelling Swelling postmarketing x x
Burning sensation Burning sensation postmarketing x
Scab Scab postmarketing x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

NAFTIFINE

Side effects:3
Source:FDA Structured Product Label

NAFTIFINE

Side effects:5
Source:FDA Structured Product Label

NAFTIFINE

Side effects:5
Source:FDA Structured Product Label

Naftifine

Side effects:10
Source:FDA Structured Product Label

Naftifine

Side effects:10
Source:FDA Structured Product Label

Color scheme:

standardalternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label